# Inhaled Amikacin Versus Placebo in Patients With Ventilator-associated Tracheobronchitis

> **NCT07665788** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University Hospital, Tours** · enrollment: 250 (estimated)

## Conditions studied

- Ventilator-Associated Pneumonia
- Ventilator-Associated Tracheobronchitis

## Interventions

- **DRUG:** Optimized and protocolized nebulization procedure.
- **DRUG:** Optimized and protocolized nebulization procedure.

## Key facts

- **NCT ID:** NCT07665788
- **Lead sponsor:** University Hospital, Tours
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2029-07-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2026-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07665788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07665788, "Inhaled Amikacin Versus Placebo in Patients With Ventilator-associated Tracheobronchitis". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07665788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*